A year-long question about a short-lived signal
A study of 14 older adults examined whether resistance training changed resting GH and IGF-1 or the acute GH response to exercise. Participants were assigned to training or a control group and underwent repeated assessments. The report did not find systematic changes in those hormone measures across the training period. [1]
This was an exercise physiology experiment, not a sermorelin treatment trial. Its relevance is to the idea that a desired adaptation must be reflected in a particular circulating hormone measurement. Research can test that assumption rather than accept it as obvious.
A response during one session is not the whole adaptation
Our interpretation is that an acute hormone peak and a long-term training outcome should be evaluated separately. A peak describes a response around an exercise session. An adaptation describes what changes over time. One may be biologically relevant without serving as a complete report card for the other.
For someone comparing a peptide program with a broader fitness plan, this distinction helps prevent misplaced attention. A laboratory change should not displace the actual goal, such as improving a task or sustaining an activity. The goal determines which outcome deserves priority when results point in different directions.
What a small physiology study leaves open
The small sample limits how confidently the result can be generalized. [1] A lack of a systematic hormone response should not be turned into a universal statement that exercise never affects GH. Equally, an unusually large response in one participant would not establish what everyone should expect.
Look for both group patterns and individual variability. A scientific report may discuss exceptions because they help frame the next experiment. A commercial summary may instead spotlight an exception as if it were typical. Asking whether a number describes an average, a subgroup or a single person is a simple way to avoid that confusion.
Keep monitoring tied to a decision
If laboratory testing is part of a proposed program, ask what decision each result is intended to change. A test should have an interpretive role, not merely create a target to chase. This is especially relevant when a service combines medication, exercise and repeated blood work in one subscription.
Our GH and strength-training analysis looks at a related but different question: whether adding GH improved strength beyond training. Read the studies according to their individual questions. Together they encourage an outcome-focused conversation while providing no basis for choosing or adjusting a sermorelin regimen from an exercise hormone graph.
The sprint-training study provides a direct example with an activity endpoint. It is a useful companion when considering whether a smaller or unchanged hormone response necessarily means the training failed.